{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:12:44Z","timestamp":1753884764828,"version":"3.41.2"},"reference-count":59,"publisher":"Open Access Pub","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JTRR"],"abstract":"<jats:p>Multiple organ dysfunction syndrome or failure is one of the major concerns against healthcare services in order to maintain the normal function. The present study aimed to explore the impact of the Biofield Energy Treated test formulation on the function of vital organs such as bones, heart, liver, lungs, and brain using standard activity parameters in specific cell-based assays. The test formulation and cells medium was divided into two parts, one untreated (UT) and other part received the Biofield Energy Treatment remotely by a renowned Biofield Energy Healer, Ariadne Esmene Afaganis, Canada and was labeled as the Biofield Treated (BT) test formulation\/media. The test formulation was tested for cell viability, and the data suggested that the test formulation was found safe and non-toxic against all the cell lines. Cytoprotective activity among the experimental groups showed a significant improved activity by 94.4% at 1 \u00b5g\/mL in untreated medium (UT-Med) + Biofield Treated Test Item (BT-TI) group in human cardiac fibroblasts cells (HCF) cells, while 84.4% at 10 \u00b5g\/mL in BT-Med + BT-TI groups in human hepatoma cells (HepG2), and 124% increased cytoprotective action at 1 \u00b5g\/mL in UT-Med + BT-TI group in adenocarcinomic human alveolar basal epithelial cells (A549) cells as compared with the untreated test group. ALP activity in MG-63 cells was significantly increased by 85.9% at 10 \u00b5g\/mL in the UT-Med + BT-TI group, while in Ishikawa cells showed maximum increased ALP activity by 59.2% at 0.1 \u00b5g\/mL in BT-Med + BT-TI groups as compared to the untreated group. The percent protection of HCF (heart) cells (decreased of LDH activity) was significantly increased by 53% and 40.5% at 1 and 10 \u00b5g\/mL concentrations respectively, in UT-Med + BT-TI group, while BT-Med + UT-TI group showed increased protection by 68.5%, 70.7%, and 16.8% at 0.1, 1, and 10 \u00b5g\/mL respectively, and 86.5%, 62.5%, and 34.2% improved cellular protection at 0.1, 1, and 10 \u00b5g\/mL respectively, in BT-Med + BT-TI group as compared to the untreated test group. The percent protection of HepG2 (liver) cells (decreased of ALT activity) was reported by 33.5%, 63.2%, and 99.2% at 10 \u00b5g\/mL in the UT-Med + BT-TI, BT-Med + UT-TI, and BT-Med + BT-TI groups, respectively compared to the untreated group. Cellular protection of A549 (lungs) cells (increased of SOD activity) in terms of percentage was increased by increased by 39.8% (at 10 \u00b5g\/mL), 44% (at 25.5 \u00b5g\/mL), and 59.7% (at 25.5 \u00b5g\/mL) in the UT-Med + BT-TI, BT-Med + UT-TI, and BT-Med + BT-TI groups, respectively compared to untreated group. Serotonin level was significantly increased by 59.2% (at 0.1 \u00b5g\/mL), 190.3% (at 0.1 \u00b5g\/mL), and 201% (at 1 \u00b5g\/mL) in the UT-Med + BT-TI, BT-Med + UT-TI, and BT-Med + BT-TI groups, respectively compared to untreated in human neuroblastoma cells (SH-SY5Y). However, the relative quantification (RQ) of vitamin D receptor (VDR) was significantly increased by 159.1% (at 50 \u00b5g\/mL), 212.7% (at 1 \u00b5g\/mL), and 278.3% (at 10 \u00b5g\/mL) in the UT-Med + BT-TI, BT-Med + UT-TI, and BT-Med + BT-TI groups, respectively as compared to the untreated in MG-63 cells. Thus, the present data concluded that the overall multiple organ health using various standard biomarkers in specific cell lines were significantly improved with respect to health of bones, heart, liver, lungs, and brain after treatment with the Biofield Energy treated test formulation (The Trivedi Effect\u00ae). Thus, it can be used as a complementary and alternative therapy approach against many multiple organ disorders such as coronary artery disease, arrhythmias, congenital heart disease, cardiomyopathy, cirrhosis, liver cancer, hemochromatosis, asthma, chronic bronchitis, cystic fibrosis, osteoporosis, etc.<\/jats:p>","DOI":"10.14302\/issn.2640-6403.jtrr-19-2946","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T09:40:20Z","timestamp":1563270020000},"page":"22-36","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Biofield Energy Treatment Based Test Formulation on Vital Organ Health Specific Biomarkers Using Cell Line Study"],"prefix":"10.14302","volume":"1","author":[{"given":"Ariadne Esmene","family":"Afaganis","sequence":"first","affiliation":[{"name":"Trivedi Global, Inc., Henderson, Nevada, USA"}]},{"given":"Mahendra Kumar","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Trivedi Global, Inc., Henderson, Nevada, USA"}]},{"given":"Alice","family":"Branton","sequence":"additional","affiliation":[{"name":"Trivedi Global, Inc., Henderson, Nevada, USA"}]},{"given":"Dahryn","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Trivedi Global, Inc., Henderson, Nevada, USA"}]},{"given":"Gopal","family":"Nayak","sequence":"additional","affiliation":[{"name":"Trivedi Global, Inc., Henderson, Nevada, USA"}]},{"given":"Mayank","family":"Gangwar","sequence":"additional","affiliation":[{"name":"Trivedi Science Research Laboratory Pvt. Ltd., Thane-West, Maharashtra, India"}]},{"given":"Snehasis","family":"Jana","sequence":"additional","affiliation":[{"name":"Trivedi Science Research Laboratory Pvt. Ltd., Thane-West, Maharashtra, India"}]}],"member":"5410","published-online":{"date-parts":[[2019,7,13]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Das L, Bhaumik E, Raychaudhuri U, Chakraborty R (2011) Role of nutraceuticals in human health. J Food Sci Technol 49(2): 173-183.","DOI":"10.1007\/s13197-011-0269-4"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Bodeker C, Bodeker G, Ong CK, Grundy CK, Burford G, Shein K. (2005). WHO Global Atlas of Traditional, Complementary and Alternative Medicine. Geneva, Switzerland: World Health Organization.","DOI":"10.1089\/acm.2006.12.93"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Bandaranayake WM (2006) Quality control, screening, toxicity, and regulation of herbal drugs, in Modern Phytomedicine. Turning Medicinal Plants into Drugs eds Ahmad I., Aqil F., Owais M., editors. (Weinheim:Wiley-VCH GmbH & Co. KGaA); 25-57.","DOI":"10.1002\/9783527609987.ch2"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Czekanska EM, Stoddart MJ, Richards RG, Hayes JS (2012) In search of an osteoblast cell model for in vitro research. Europ Cells Mat 24: 1-17.","DOI":"10.22203\/ecm.v024a01"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Xiang-hang Luo and Er-yuan Liao. (2003). Effects of Estriol on the Proliferation and Differentiation of Human Osteoblastic MG-63 Cells. End Res 29(3): 343-351.","DOI":"10.1081\/erc-120025041"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Schaefer WR, Fischer L, Deppert WR, Hanjalic-Beck A, Seebacher L, Weimer M, Zahradnik HP. (2010). In vitro-Ishikawa cell test for assessing tissue-specific chemical effects on human endometrium 30(1): 89-93.","DOI":"10.1016\/j.reprotox.2010.02.002"},{"key":"ref6","unstructured":"7. Melissa PSW, Navaratnam V, Yin CY (2013) Estrogenic assessment of Labisia Pumila extracts using a human endometrial cell line. Int J Pharm Pharmaceutical Sci 5(2): 448-452."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Su Wei Poh M, Voon Chen Yong P, Viseswaran N, Chia YY (2015) Estrogenicity of Glabridin in Ishikawa Cells. PLoS ONE 10(3): e0121382.","DOI":"10.1371\/journal.pone.0121382"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Valavanidis A Vlachogianni T, Fiotakis K, Loridas S (2013) Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. Int J Environ Res Public Health 10(9): 3886-3907.","DOI":"10.3390\/ijerph10093886"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Bouma ME, Rogier E, Verthier N, Labarre C, Feldmann G (1989) Further cellular investigation of the human hepatoblastoma-derived cell line HepG2: Morphology and immunocytochemical studies of hepatic-secreted proteins. In Vitro Cell Dev Biol 25: 267-75.","DOI":"10.1007\/bf02628465"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Bak MJ, Jun M, Jeong WS (2012) Antioxidant and hepatoprotective effects of the red ginseng essential oil in H(2)O(2)-treated hepG2 cells and CCl              (4)-treated mice. Int J Mol Sci 13(2): 2314-2330.","DOI":"10.3390\/ijms13022314"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Al\u00eda M, Ramos S, Mateos R, Bravo L, Goya L (2005) Response of the antioxidant defense system to         tert-butyl hydroperoxide and hydrogen peroxide in a human hepatoma cell line (HepG2). J Biochem Mol Toxicol 19(2): 119-28.","DOI":"10.1002\/jbt.20061"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Molavi B, Mehta JL (2004) Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol 19: 488-93.","DOI":"10.1097\/01.hco.0000133657.77024.bd"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Kumar S, Gupta S (2011) Thymosin Beta 4 Prevents Oxidative Stress by Targeting Antioxidant and         Anti-Apoptotic Genes in Cardiac Fibroblasts. PLoS ONE 6: e26912.","DOI":"10.1371\/journal.pone.0026912"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15. Meneses A, Liy-Salmeron G (2012) Serotonin and emotion, learning and memory. Rev Neurosci23(5-6): 543-53.","DOI":"10.1515\/revneuro-2012-0060"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Rohm B, Holik AK, Somoza MM, Pignitter M, Zaunschirm M, Ley JP, Krammer GE, Somoza V (2013) Nonivamide, a capsaicin analog, increases dopamine and serotonin release in SH-SY5Y cells via a TRPV1-independent pathway. Mol Nutr Food Res 57(11): 2008-2018.","DOI":"10.1002\/mnfr.201200846"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner Res 13: 325-349.","DOI":"10.1359\/jbmr.1998.13.3.325"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Brown AJ, Brown AJ, Slatopolsky E (1999) Vitamin D. Am J Physiol Renal Physiol 277: F157-F175.","DOI":"10.1152\/ajprenal.1999.277.2.f157"},{"key":"ref18","unstructured":"19.  Global Burden of Disease Collaborative Network.Global Burden of Disease Study Results(2016).Seattle, United States: Institute for Health Metrics and Evaluation (IHME),2017."},{"key":"ref19","unstructured":"20. Pal S (2018) Incidence and prevalence of major neurologic disorders. US Pharm 43(1): 24."},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Movaffaghi Z, Farsi M (2009) Biofield therapies: Biophysical basis and biological regulations. Complement Ther Clin Pract 15: 35-37.","DOI":"10.1016\/j.ctcp.2008.07.001"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States2002. Adv Data 343: 1-19.","DOI":"10.1016\/j.sigm.2004.07.003"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States2007. Natl Health Stat Report 12: 1-23.","DOI":"10.1037\/e623942009-001"},{"key":"ref23","unstructured":"24. Fan K wai (2005) National Center for Complementary and Alternative Medicine Website. J Med Libr Assoc 93: 410-412."},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Trivedi MK, Tallapragada RM (2008) A transcendental to changing metal powder characteristics. Met Powder Rep 63: 22-28, 31.","DOI":"10.1016\/s0026-0657(08)70145-0"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Trivedi MK, Nayak G, Patil S, Tallapragada RM, Latiyal O (2015) Studies of the atomic and crystalline characteristics of ceramic oxide nano powders after bio field treatment. IndEng Manage 4: 161.","DOI":"10.4172\/2169-0316.1000161"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, Jana S (2015) Morphological characterization, quality, yield and DNA fingerprinting of biofield energy treated alphonso mango (Mangifera indica L.). Journal of Food and Nutrition Sciences 3: 245-250.","DOI":"10.11648\/j.jfns.20150306.18"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Trivedi MK, Branton A, Trivedi D, Nayak G, Charan S, Jana S (2015) Phenotyping and 16S rDNA analysis after biofield treatment on Citrobacter braakii: A urinary pathogen. J Clin Med Genom 3: 129.","DOI":"10.4172\/2332-0672.1000129"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015). Evaluation of biofield modality on viral load of Hepatitis B and C viruses. J Antivir Antiretrovir 7: 083-088.","DOI":"10.4172\/jaa.1000123"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) Phenotypic and biotypic characterization of Klebsiella oxytoca: An impact of biofield treatment. J Microb Biochem Technol 7: 203-206.","DOI":"10.4172\/1948-5948.1000205"},{"key":"ref30","unstructured":"31. Nayak G, Altekar N (2015). Effect of biofield treatment on plant growth and adaptation. J Environ Health Sci 1: 1-9."},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Branton A, Jana S. (2017) The influence of energy of consciousness healing treatment on low bioavailable resveratrol in male Sprague Dawley rats. International Journal of Clinical and Developmental Anatomy 3: 9-15.","DOI":"10.11648\/j.ijcda.20170303.11"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Branton A, Jana S (2017) The use of novel and unique biofield energy healing treatment for the improvement of poorly bioavailable compound, berberine in male Sprague Dawley rats. American Journal of Clinical and Experimental Medicine 5: 138-144.","DOI":"10.11648\/j.ajcem.20170504.16"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Kinney JP, Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, Jana S (2017) Overall skin health potential of the biofield energy healing based herbomineral formulation using various skin parameters. American Journal of Life Sciences 5:             65-74.","DOI":"10.11648\/j.ajls.20170502.15"},{"key":"ref34","unstructured":"35. Singh J, Trivedi MK, Branton A, Trivedi D, Nayak G, Gangwar M, Jana S (2017) Consciousness energy healing treatment based herbomineral formulation: A safe and effective approach for skin health. American Journal of Pharmacology and Phytotherapy 2: 1-10."},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Trivedi MK, Branton A, Trivedi D, Nayak G, Plikerd WD, Surguy PL, Kock RJ, Piedad RB, Callas RP, Ansari SA, Barrett SL, Friedman S, Christie SL, Liu SC, Starling SE, Jones S, Allen SM, Wasmus SK, Benczik TA, Slade TC, Orban T, Vannes VL, Schlosser VM, Albino YSY, Panda P, Sethi KK, Jana S (2017) A Systematic study of the biofield energy healing treatment on physicochemical, thermal, structural, and behavioral properties of magnesium gluconate. International Journal of Bioorganic Chemistry 2: 135-145.","DOI":"10.4172\/2157-7064.1000292"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) The potential impact of biofield treatment on human brain tumor cells: A time-lapse video microscopy. J Integr Oncol 4: 141.","DOI":"10.4172\/2329-6771.1000141"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Anagnos D, Trivedi K, Branton A, Trivedi D, Nayak G, Mondal SC, Jana S (2018) Influence of biofield treated vitamin D3 on proliferation, differentiation, and maturation of bone-related parameters in MG-63 cell-line. International Journal of Biomedical Engineering and Clinical Science 4: 6-14.","DOI":"10.11648\/j.ijbecs.20180401.12"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39. Lee AC, Trivedi K, Branton A, Trivedi D, Nayak G, Mondal SC, Jana S (2018) The potential benefits of biofield energy treated vitamin D3 on bone mineralization in human bone osteosarcoma cells (MG-63). International Journal of Nutrition and Food Sciences 7: 30-38.","DOI":"10.19080\/jcmah.2018.07.555725"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40. Stutheit ME, Trivedi K, Branton A, Trivedi D, Nayak G, Mondal SC, Jana S (2018) Biofield energy treated vitamin D3: Therapeutic implication on bone health using osteoblasts cells. American Journal of Life Sciences 6: 13-21.","DOI":"10.11648\/j.ajls.20180601.13"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41. Al\u00eda M, Ramos S, Mateos R, Bravo L, Goya L (2005) Response of the antioxidant defense system to             tert-butyl hydroperoxide and hydrogen peroxide in a human hepatoma cell line (HepG2). J Biochem Mol Toxicol 19: 119-128.","DOI":"10.1002\/jbt.20061"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"42. Vargas-Mendoza N, Madrigal-Santill\u00e1n E,                   Morales-Gonz\u00e1lez A, Esquivel-Soto J, Esquivel-Chirino C, et al. (2014) Hepatoprotective effect of silymarin. World J Hepatol 6: 144-149.","DOI":"10.4254\/wjh.v6.i3.144"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43. Al\u00eda M, Ramos S, Mateos R, Bravo L, Goya L (2005) Response of the antioxidant defense system to               tert-butyl hydroperoxide and hydrogen peroxide in a human hepatoma cell line (HepG2). J Biochem Mol Toxicol 19(2): 119-28.","DOI":"10.1002\/jbt.20061"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"44. Videla LA (2009) Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. World J Hepatol 1: 72-78.","DOI":"10.4254\/wjh.v1.i1.72"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45. Sha Li, Hor-Yue Tan, Ning Wang, Zhang-Jin Zhang, Lixing Lao et al. (2015) The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci 16: 26087-26124.","DOI":"10.3390\/ijms161125942"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"46. Cheresh P, Kim SJ, Tulasiram S, Kamp DW (2013) Oxidative stress and pulmonary fibrosis. Biochim Biophys Acta 1832: 1028-1040.","DOI":"10.1016\/j.bbadis.2012.11.021"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"47. Lu LY, Ou N, Lu QB (2013) Antioxidant induces DNA damage, cell death and mutagenicity in human lung and skin normal cells. Sci Rep 3: 3169.","DOI":"10.1038\/srep03169"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48. Gerald J, Atkins, David M. Findlay, Paul H, Anderson, Howard A, Morris, Vitamin D. (2011).(Third Edition),Vitamin D - Target Genes: Bone Proteins.Chapter23, 1: 411-424.","DOI":"10.1016\/b978-0-12-381978-9.10023-x"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"49. Emami A, Larsson A, Petr\u00e9n-Mallmin M, Larsson S (1999) Serum bone markers after intramedullary fixed tibial fractures. Clin Orthop Relat Res 368:              220-229.","DOI":"10.1097\/00003086-199911000-00027"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"50. Burgner JW, Ray WJ (1984) On the origin of the lactate dehydrogenase induced rate effect. Biochemistry 23: 3636-3648.","DOI":"10.1021\/bi00311a010"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"51. Valvona CJ, Fillmore HL, Nunn PB, Pilkington GJ (2015) The regulation and function of lactate dehydrogenase A: Therapeutic potential in brain tumor. Brain Pathol 26: 3-17.","DOI":"10.1111\/bpa.12299"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"52. Kopperschl\u00e4ger G, Kirchberger J (1996) Methods for the separation of lactate dehydrogenases and clinical significance of the enzyme. J Chromatogr B Biomed Appl684(1-2): 25-49.","DOI":"10.1016\/0378-4347(96)00133-8"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"53. Pratt DS, Kaplan MM (2000) Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 342: 1266-1271.","DOI":"10.1056\/nejm200004273421707"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"54. Mathiesen U, Franzen L, Fryden A, Foberg U, Bodemar G (1999) The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol 34:             85-91.","DOI":"10.1097\/00042737-199904000-00025"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"55. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O (2012) Oxidative stress and antioxidant defense. World Allergy Organ J 5(1): 9-19.","DOI":"10.1097\/wox.0b013e3182439613"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"56. Meltzer CC, Smith G, DeKosky ST, Pollock BG, Mathis CA, Moore RY, Kupfer DJ, Reynolds CF (1998) Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 18: 407-430.","DOI":"10.1016\/s0893-133x(97)00194-2"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"57. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349.","DOI":"10.1359\/jbmr.1998.13.3.325"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"58. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135: 317-322.","DOI":"10.1093\/jn\/135.2.317"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"59. Carlberg C, Moln\u00e1r F (2012) Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem 12: 528-547.","DOI":"10.2174\/156802612799436623"}],"container-title":["Journal of Tissue Repair and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openaccesspub.org\/jtrr\/article\/1131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T09:40:30Z","timestamp":1563270030000},"score":1,"resource":{"primary":{"URL":"https:\/\/openaccesspub.org\/jtrr\/article\/1131"}},"subtitle":[],"editor":[{"given":"Jun","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics, Indiana University School of Medicine, USA."}]}],"short-title":[],"issued":{"date-parts":[[2019,7,13]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,11,29]]}},"URL":"https:\/\/doi.org\/10.14302\/issn.2640-6403.jtrr-19-2946","relation":{},"ISSN":["2640-6403"],"issn-type":[{"type":"electronic","value":"2640-6403"}],"subject":[],"published":{"date-parts":[[2019,7,13]]},"article-number":"1131"}}